Swiss National Bank Dexcom Inc Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Dexcom Inc stock. As of the latest transaction made, Swiss National Bank holds 1,180,400 shares of DXCM stock, worth $94.5 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,180,400

Previous 1,141,400 3.42%

Holding current value

$94.5 Million

Previous $129 Million 38.87%

% of portfolio

0.05%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$64.0 - $116.06 $2.5 Million - $4.53 Million	39,000 Added 3.42%	1,180,400 $79.1 Million
Q2 2024 Aug 08, 2024	SELL	$110.31 - $140.45 $1.73 Million - $2.21 Million	-15,700 Reduced 1.36%	1,141,400 $129 Million
Q1 2024 May 07, 2024	SELL	$114.22 - $140.1 $6.37 Million - $7.82 Million	-55,800 Reduced 4.6%	1,157,100 $160 Million
Q4 2023 Feb 06, 2024	SELL	$75.49 - $124.16 $2.57 Million - $4.22 Million	-34,000 Reduced 2.73%	1,212,900 $151 Million
Q3 2023 Nov 08, 2023	SELL	$86.06 - $137.93 $13.2 Million - $21.1 Million	-153,100 Reduced 10.94%	1,246,900 $116 Million
Q2 2023 Aug 09, 2023	SELL	$112.47 - $130.98 $14.9 Million - $17.4 Million	-132,800 Reduced 8.66%	1,400,000 $180 Million
Q1 2023 May 10, 2023	SELL	$104.0 - $122.92 $6.53 Million - $7.72 Million	-62,800 Reduced 3.94%	1,532,800 $178 Million
Q4 2022 Feb 08, 2023	SELL	$84.98 - $122.67 $8.95 Million - $12.9 Million	-105,376 Reduced 6.2%	1,595,600 $181 Million
Q3 2022 Nov 09, 2022	BUY	$76.35 - $94.18 $1.28 Million - $1.58 Million	16,800 Added 1.0%	1,700,976 $137 Million
Q2 2022 Aug 09, 2022	BUY	$67.99 - $132.89 $86 Million - $168 Million	1,264,332 Added 301.14%	1,684,176 $126 Million
Q1 2022 May 09, 2022	BUY	$94.08 - $130.2 $4.9 Million - $6.78 Million	52,100 Added 14.17%	419,844 $215 Million
Q4 2021 Feb 08, 2022	SELL	$129.87 - $162.82 $1.9 Million - $2.38 Million	-14,600 Reduced 3.82%	367,744 $197 Million
Q3 2021 Nov 08, 2021	SELL	$106.71 - $143.18 $1.05 Million - $1.4 Million	-9,800 Reduced 2.5%	382,344 $209 Million
Q2 2021 Aug 06, 2021	BUY	$80.99 - $107.93 $1.85 Million - $2.46 Million	22,837 Added 6.18%	392,144 $167 Million
Q1 2021 May 07, 2021	BUY	$84.79 - $104.74 $652,883 - $806,498	7,700 Added 2.13%	369,307 $133 Million
Q4 2020 Feb 05, 2021	BUY	$78.0 - $104.5 $171,600 - $229,900	2,200 Added 0.61%	361,607 $134 Million
Q3 2020 Nov 09, 2020	SELL	$95.51 - $112.95 $267,428 - $316,260	-2,800 Reduced 0.77%	359,407 $148 Million
Q2 2020 Aug 05, 2020	BUY	$62.68 - $105.34 $432,492 - $726,846	6,900 Added 1.94%	362,207 $147 Million
Q1 2020 May 08, 2020	BUY	$47.79 - $75.63 $3.24 Million - $5.13 Million	67,800 Added 23.58%	355,307 $95.7 Million
Q4 2019 Feb 06, 2020	SELL	$36.62 - $57.29 $479,721 - $750,499	-13,100 Reduced 4.36%	287,507 $62.9 Million
Q3 2019 Nov 12, 2019	BUY	$35.53 - $43.8 $266,723 - $328,806	7,507 Added 2.56%	300,607 $44.9 Million
Q2 2019 Aug 02, 2019	SELL	$27.84 - $38.92 $83,520 - $116,760	-3,000 Reduced 1.01%	293,100 $43.9 Million
Q1 2019 May 10, 2019	BUY	$28.07 - $38.18 $249,823 - $339,802	8,900 Added 3.1%	296,100 $35.3 Million
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $3.61 Million - $4.99 Million	133,600 Added 86.98%	287,200 $34.4 Million
Q3 2018 Nov 08, 2018	BUY	$23.35 - $36.72 $35,025 - $55,080	1,500 Added 0.99%	153,600 $22 Million
Q2 2018 Aug 09, 2018	BUY	$17.54 - $25.22 $22,802 - $32,786	1,300 Added 0.86%	152,100 $14.4 Million
Q1 2018 May 04, 2018	BUY	$13.06 - $18.54 $44,404 - $63,036	3,400 Added 2.31%	150,800 $11.2 Million
Q4 2017 Feb 07, 2018	SELL	$11.12 - $15.38 $1.9 Million - $2.63 Million	-171,000 Reduced 53.71%	147,400 $8.46 Million
Q3 2017 Nov 03, 2017	BUY	$11.36 - $18.98 $3.62 Million - $6.04 Million	318,400	318,400 $15.6 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Dexcom Inc Transaction History